Clinical Trial Update: High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy [NA]

View source ↗

Summary

Clinical trial comparing high-dose ACE inhibitor therapy to a combination of ACE and ARB therapy in diabetic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Diabetic Kidney Disease | NA | Status: COMPLETED